OpenURL Connection Search

Select item for more details and to access through your institution.

Impact of HPV testing in opportunistic cervical screening: Support for primary HPV screening in the United States.
Published in:
International Journal of Cancer, 2023, v. 153, n. 1, p. 83, doi. 10.1002/ijc.34519
By:
- Cuzick, Jack;
- Adcock, Rachael;
- Kinney, Walter;
- Castle, Philip E.;
- Robertson, Michael;
- McDonald, Ruth M.;
- Stoler, Mark H.;
- Du, Ruofei;
- Wheeler, Cosette M.
Publication type:
Article
DNA methylation testing with S5 for triage of high‐risk HPV positive women.
Published in:
International Journal of Cancer, 2022, v. 151, n. 7, p. 993, doi. 10.1002/ijc.34050
By:
- Adcock, Rachael;
- Nedjai, Belinda;
- Lorincz, Attila T.;
- Scibior‐Bentkowska, Dorota;
- Banwait, Rawinder;
- Torrez‐Martinez, Norah;
- Robertson, Michael;
- Cuzick, Jack;
- Wheeler, Cosette M.
Publication type:
Article
Combined use of cytology, p16 immunostaining and genotyping for triage of women positive for high‐risk human papillomavirus at primary screening.
Published in:
International Journal of Cancer, 2020, v. 147, n. 7, p. 1864, doi. 10.1002/ijc.32973
By:
- Cuzick, Jack;
- Adcock, Rachael;
- Carozzi, Francesca;
- Gillio‐Tos, Anna;
- De Marco, Laura;
- Del Mistro, Annarosa;
- Frayle, Helena;
- Girlando, Salvatore;
- Sani, Cristina;
- Confortini, Massimo;
- Zorzi, Manuel;
- Giorgi‐Rossi, Paolo;
- Rizzolo, Raffaella;
- Ronco, Guglielmo
Publication type:
Article
Human papilloma virus genotyping for the cross‐sectional and longitudinal probability of developing cervical intraepithelial neoplasia grade 2 or more.
Published in:
International Journal of Cancer, 2018, v. 143, n. 2, p. 333, doi. 10.1002/ijc.31326
By:
- Del Mistro, Annarosa;
- Adcock, Rachael;
- Carozzi, Francesca;
- Gillio‐Tos, Anna;
- De Marco, Laura;
- Girlando, Salvatore;
- Rizzolo, Raffaella;
- Frayle, Helena;
- Trevisan, Morena;
- Sani, Cristina;
- Burroni, Elena;
- Giorgi Rossi, Paolo;
- Cuzick, Jack;
- Ronco, Guglielmo;
- the New Technologies for Cervical CancerWorking Group
Publication type:
Article
Relationships of p16 Immunohistochemistry and Other Biomarkers With Diagnoses of Cervical Abnormalities: Implications for LAST Terminology.
Published in:
Archives of Pathology & Laboratory Medicine, 2020, v. 144, n. 6, p. 725, doi. 10.5858/arpa.2019-0241-OA
By:
- Castle, Philip E.;
- Adcock, Rachael;
- Cuzick, Jack;
- Wentzensen, Nicolas;
- Torrez-Martinez, Norah E.;
- Torres, Salina M.;
- Stoler, Mark H.;
- Ronnett, Brigitte M.;
- Joste, Nancy E.;
- Darragh, Teresa M.;
- Gravitt, Patti E.;
- Schiffman, Mark;
- Hunt, William C.;
- Kinney, Walter K.;
- Wheeler, Cosette M.
Publication type:
Article

Found: 5

Impact of HPV testing in opportunistic cervical screening: Support for primary HPV screening in the United States.

DNA methylation testing with S5 for triage of high‐risk HPV positive women.

Combined use of cytology, p16 immunostaining and genotyping for triage of women positive for high‐risk human papillomavirus at primary screening.

Human papilloma virus genotyping for the cross‐sectional and longitudinal probability of developing cervical intraepithelial neoplasia grade 2 or more.

Relationships of p16 Immunohistochemistry and Other Biomarkers With Diagnoses of Cervical Abnormalities: Implications for LAST Terminology.